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• Review the challenges to decipher the glycocode. 
• Tools and repositories for investigating the protein-carbohydrate complexes. 
• Experimental and computational methods for studying protein-carbohydrate 
interactions and to gain insights into dynamics and understand conformational changes. 
• Recent molecular and cellular biology techniques (such as gene editing) and glycan 
engineering are very useful to understand the glycome. 
Abstract 
Carbohydrates represent one of the building blocks of life, along with nucleic acids, proteins 
and lipids. Although glycans are involved in a wide range of processes from embryogenesis to 
protein trafficking and pathogen infection, we are still a long way from deciphering the 
glycocode. In this review, we aim to present a few of the challenges that researchers working 
in the area of glycobiology can encounter and what strategies can be utilised to overcome them. 
Our goal is to paint a comprehensive picture of the current saccharide landscape available in 
the Protein Data Bank (PDB). We also review recently updated repositories relevant to the 
topic proposed, the impact of software development on strategies to structurally solve 
carbohydrate moieties, and state-of-the-art molecular and cellular biology methods that can 













Compared to other essential biological building blocks such as nucleotides and 
proteins/peptides, the complexity of saccharides, as a class, is far greater. This is due to the 
variety of monosaccharide diversity, coupling, branching and anomeric states, as well as their 
ability to form free glycans or glycoconjugates (e.g. glycosylation, gangliosides). Furthermore, 
cell surface and secreted glycans present the lowest evolutionary conservation and exhibit the 
highest informational and structural diversity [1••]. Efforts to elucidate the combinatorial 
conundrum posed by the versatility of sugars have been purely theoretical, relying on 
approximations. The most recent number of  putative combinations for  hexa-saccharides is 
estimated to be 1.9	 × 10'', taking into account precise restrictions based on the chemical 
capacities of ten mammalian monosaccharides and anomeric expansion [2]. This number is 
several orders of magnitude larger than estimates for hexa-nucleic acids (4096 combinations) 
and hexa-peptides (6.4	 ×	10* combinations). 
One of the obstacles in deciphering the glycocode is the lack of a template from which the end-
product glycans can be derived, unlike proteins that are coded by mRNA. Instead, glycan 
structures result from a complex interplay between partners that vary between cell types and 
cellular compartments. This complex, variable biological machinery gives rise to further 
complexity through “microheterogeneity”, where a protein within the same cell/tissue can 
exhibit different glycoforms (glycosylation motifs),  and “macroheterogeneity”, where a 
protein can be glycosylated differently in different tissues [3].  
Analysis of three-dimensional glycan-protein interactions, whether inter- or intra-molecular, 
could provide insights into the issues described above. Currently, there are ~5000 protein-
carbohydrate (non-covalently bound) complexes (as reported in ProCarbDB [4•]) and ~7000 
glycosylated structures (as reported in GlycanReader [5•]) in the Protein Data Bank [6]. 
However, analysing carbohydrate-containing structures is a non-trivial task, partly due to their 
complex and branched nature, as well as functional modifications of the monomeric units. In a 
recent review, Joosten and Lutteke [7•] provide a comprehensive picture of the challenges that 
structural biochemists must overcome in the field of glycoscience. The most important of these 
challenges are briefly listed below: 
1) Not all saccharide moieties are correctly annotated in the PDB [8,9]. 
2) Significant errors in the structural rendering, partially due to incomplete electron 
density maps [7•,9], especially missing or incorrect glycosidic bonds. 
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3) Ligands might not be in the biologically relevant environment (i.e. missing aliphatic 
chains or acting as crystallographic additives bearing no biological role) and thus 
protein-carbohydrate interfaces cannot be correctly characterized [4•,10•]. 
4) Presence of non-host glycosylation motifs based on the expression system’s 
carbohydrate repertoire [11•]. 
5) Scarcity of available glycan chains in the PDB, under 10% [5•], although more than 
50% of proteins are estimated to present some level of glycosylation [12].  
New repositories in glycobiology 
Currently, there are issues regarding saccharide annotation (e.g. GlycosciencesDB.DE [13] 
identifies 776 monosaccharides while the PDB recognizes less than 600), as well as validation 
issues with carbohydrate moieties in the PDB. Thus, researchers have curated structural 
[4,5,14••–19••] and annotation [18–23] databases (Table 1) specifically for glycan binding 
proteins (GBPs) and saccharide containing structures. Unilectin3D (last updated in 2019) hosts 
experimentally solved structures for lectins, across all kingdoms (including viruses) [15]. 
Enzymes involved in carbohydrate synthesis or breakdown are extensively covered in CaZy 
(Carbohydrate-active enzyme) database [19]. The authors have mapped all possible structures 
from the PDB to their enzyme nomenclature. In doing this they have also, identifed over 100 
types of carbohydrate-like molecules as biologically relevant ligands. Another useful online 
resource for glycan structures and motifs is GlyTouCan [14], which hosts over 100,000 
carbohydrate structures and identifies 800 monosaccharides. The recently developed repository 
ProCarbDB identifies all protein-carbohydrate (non-covalently bound) complexes including 
those of enzymes, lectins, antibodies and transporter proteins [4]. Resources combining glycan 
structural information with data from nuclear magnetic resonance (NMR) experiments have 
also been developed in recent years: Carbohydrate Structure Database (CSDB) [17] and Glyco 
3D [16]. Glycan Reader (last updated in 2018) is another useful resource which can 
automatically identify and annotate glycans within a PDB file, recognize glycosidic linkages 
and set up the glycan-protein complex for simulation using the CHARMM force field [5•]. 
Finally, DAGR (Database of Anti-Glycan Reagents) is a very useful repository for molecular 
biologists, because it offers a glycan IUPAC text search in order to identify the best antibody 
for a particular motif [23]. 
In order to provide a comprehensive picture of the available structural information for 
saccharide containing structures and apo-GBPs, we analysed the four largest and recently 
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updated datasets: Glycan Reader, CAZy, Unilectin3D and ProCarbDB. We have identified 
overlaps between these datasets as well as specific knowledge domains (Figure 1A). 
Unilectin3D and CAZy are hosting both apo and glycan bound forms of lectins and 
carbohydrate enzymes, respectively. Thus, it is not surprising that the majority (over 90%) of 
the unique entries (not overlapping with any other dataset) for both Unilectin3D and CAZy do 
not have a ligand. Glycan Reader identifies all carbohydrate moieties (including chemical 
modifications) present in the PDB, based on automated recognition of carbohydrates. In the 
subset of its unique entries, 68% are glycosylated non-GBPs. ProCarbDB hosts only protein-
carbohydrate complexes, and thus in theory all its entries should be part of the Glycan Reader 
dataset. However, there are some ProCarbDB entries which are not present in the Glycan 
Reader dataset (such as 5M63 and 6B0K). This is due to the larger saccharide dictionary 
(merged set between PDB and pdb-care annotations) used in ProCarbDB. Another set of unique 
structures present only in Glycan Reader are those that have been crystallised using glycan 
containing surfactants compounds, such as β-octylglucoside (PDB Ligand ID: BOG), which is 
a crystallographic additive in the PDB structure 5ML5 and has no reported biological role. The 
divergence between datasets can be explained based on specificity, definition of carbohydrate 
moieties, biological function (or lack thereof) of the ligand and presence of obsolete structures. 
Due to the presence of unique entries in each of the four repositories mentioned above, we 
merged everything into a unique set of 20,505 PDB structures and mapped each structure to its 
date of release (Figure 1B). The percentage per year of released structures either containing a 
saccharide moiety or describing a GBP is more or less constant (between 10-15%) for the last 
10 years. Most of the structures, (19642 - 95.7%), present in the above-mentioned set were 
solved by X-ray crystallography, followed by electron microscopy, (323 - 1.6%), solution 
NMR, (241 - 1.2%) and other techniques, (69 - 0.3%). The remaining structures, (230 - 1.2%) 
are obsolete structures still present to some extent in all the datasets with the exception of 
ProCarbDB, which presently has no obsolete structures. Interestingly, the number of crystal 
structures solved by electron microscopy has steadily increased over the past 6 years: from 
only 4 structures containing saccharide moieties solved in 2014 to 122 in 2018 and already 83 
by August 2019. 
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Structures containing glycans 
The intrinsic flexibility of glycosidic linkages makes obtaining crystals for X-ray experiments 
a difficult and a time-consuming task. Other techniques such as NMR and computational 
techniques, including mathematical modelling and molecular dynamics (MD), might provide 
insights into different conformations of GBPs [24,25].  
NMR approaches were  used, for example, to define protein-glycan interfaces and the affinity 
for heparin of proMMP-7 (matrix metalloproteinase-7 zymogen) complex in solution [26]. 
Recently, several structural approaches (such as NMR, X-ray crystallography and cryo-EM) 
supported by MD simulations have been used to shed light on dynamic processes occurring in 
bacterial membranes such as: conformational preference and dynamics of O-antigen in E. coli 
[27], processing and elongation of peptidoglycans [28], biological and biophysical behaviour 
of bacterial membranes [29], protein-outer membrane interactions [30–32], and sugar transport 
[33•].  
Other fields benefiting from the power of MD simulations are pathology and immunology, 
especially in areas concerning: antigenicity and immunogenicity [34–37], and identification of 
novel structural motifs [38,39]. The interactions between interleukin-10 (IL-10) and its ligand 
glycosaminoglycans (GAG) have been defined using X-ray crystallography (apo IL-10), NMR 
(IL-10-GAG complex), molecular docking and MD simulations [40]. In an another example, 
small angle X-ray scattering and mathematical modelling were used characterise CC 
chemokine ligand (CCL) 5 oligomerisation process and unveil the interactions of CCL5 an 
CCL3 with GAG [41]. Recently, a 3.6Å cryo-EM structure of the icosahedral capsid of the 
porcine circovirus 2 complex with heparin was solved and identified the non-symmetrical 
distribution of heparin to the icosahedral virus [42]. Cryo-EM has also been used to solve the 
structures of membrane bound proteins such as ATP binding cassette transporters (comprising 
of lipopolysaccharides transport protein subunits) in bacteria [43••]. 
The N-glycosylation landscape was analysed by Lee et al. and statistically no significant global 
conformational change was recorded between glycosylated and de-glycosylated forms of the 
same protein [44•]. However, this result contradicts a previous study by Xin and Radivojac 
[45]. Lee et al., performed 200-ns MD simulations that showed decreased dynamics upon 
glycosylation, not at the glycosylation site itself, but allosterically in other regions. Suga et al. 
performed a different holistic analysis on the N-glycosylation available in the PDB focusing 
on the processing and maturation of glycosylation [11•]. They found that the accessible surface 
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area (ASA) of immaturely glycosylated (only the early steps in glycosylation) asparagine is 
lower than that of mature glycans. The authors conducted a protein surface analysis around the 
N-glycosylation sites and suggested that there is an overall bias for γ-branched amino acids 
(Asn, Asp and Leu) distribution around the immature N-glycans.  However, these analyses use 
the currently available data, which are limited. Furthermore, we can only inspect the glycan 
patterns of the fully folded proteins. 
Although three-dimensional glycosylation data are limited and biased, a number of 
bioinformatic tools were developed recently for predicting [46], validating [47••], identifying 
[5,9], modelling [48–53] and simulating [49••,54] structures that contain glycan moieties 
(Table 2). The choice of modelling software depends on the experimental details and MD 
simulation program used. However, all bioinformatics tools presented in Table 2 are reported 
to generate three-dimensional glycan structures with good confidence (i.e. low root mean 
square deviation (RMSD) between the modelled and the experimentally generated glycan 
three-dimensional structures).  
There are limitations of current approaches and usually each software has a different 
nomenclature scheme for encoding carbohydrates, which makes it difficult for the users to 
utilise multiple programs with one protocol. Furthermore, only CHARMM-GUI set of tools 
can be used with all major MD simulation programs, which further limits experimental design.   
Protein-carbohydrate interactions 
Protein-carbohydrate interaction partners can be identified by using high-throughput assays 
such as glycan arrays [55] or lectin arrays [56]. Manual interpretation of the results is a very 
laborious and time-consuming task. However, a couple of recently developed algorithms (e.g. 
GlycoSearch [57] and MACAW (Multiple Carbohydrate Alignment with Weights) [58]) can 
automatically analyse glycan array data.  
As explained in the introduction of this review, comprehending the diversity of glycans has 
been achieved largely using theoretical approaches and the structural information available is 
limited and prone to mistakes. Thus, any currently viable algorithm developed either for 
statistical analysis or prediction of protein-carbohydrate interactions is highly specific for one 
type of GBP. Samsonov et al. have analysed protein-glycosaminoglycan (GAG) interactions 
using MD simulations and uncovered interactions between GAG processing enzymes and their 
ligands that are less electrostatics driven than interactions between GAG binding proteins 
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(lacking enzymatic activity) and their ligands. Furthermore, they proved that Poisson–
Boltzmann surface area (PBSA)-based electrostatic potential calculations are robust enough to 
predict putative GAG-binding regions [59]. 
With the revolution of machine learning at the beginning of this decade, a couple of algorithms 
have also been developed in the field of glycobiology. Nassif et al. tried to predict protein-
glucose binding sites using support vector machines (SVM) [60]. They used random forest 
(RF) as a feature selection tool and identified critical variables for accurate predictions 
including charge, hydrogen bonding ability, hydrophobicity, type of residues as well as the 
presence of ordered water molecules and ions present in the X-ray crystal structure. The 
surprising result is that amongst all chemical properties described above both hydrophobicity 
and charge are more important than hydrogen bonding ability. Their algorithm achieved 8.11% 
error, 89.66% sensitivity and 93.33% specificity over their dataset.  
A more recent article by Pai et al. aimed to predict protein-mannose interacting residues using 
both SVM and RF [61]. They identified position-specific scoring matrix (PSSM) as being a 
better feature set than local amino acid composition for predicting mannose-interacting 
residues. They report a significant improvement in specificity, sensitivity and precision when 
compared to other state-of-art predictors.  
Although these results show good results for very specific tasks it is important to point out one 
caveat: any machine learning program requires accurate and large training sets, devoid of false 
positive entries and duplicates, in order to generate accurate predictions. Nevertheless, by 
carefully analysing each individual dataset, we were able to identify false positive entries. The 
degree to which those entries skew the results is outside the scope of this article. 
Recent molecular and cellular biology tools to investigate the glycome 
The current structural information on carbohydrate moieties and motifs as a whole is sparse, 
not aggregated, non-uniform and sometimes even conflicting. At the same time our knowledge 
about the importance of glycans in protein uptake, trafficking and localization is opening new 
avenues for the generation of highly specific therapeutic agents using carbohydrates, and their 
analogues [1]. Since there is little structural information available, generating controlled 
glycan-patterns can be used as an alternative to probe binding pockets for GPBs [62••,63]. 
With the engineering of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) 
associated protein 9 (CAS9) and zinc finger nucleases (ZFN), targeted and refined cell-based 
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assays are now available in glycobiology [64]. Basic research has harvested the power of these 
molecular tools to:  
1) Generate a guide RNA (gRNA) library targeting all known glycosyltransferases in 
HEK297 cells (Human Embryonic Kidney cells) [65•]. 
2) Control-synthesize a large part of the human glycome [66]. 
3) Understand the redundancy and specificity of O-glycosylation pathways [67]. 
4) Generate specific monoclonal antibodies against mucin-type O-glycosylation [68•]. 
Translational research has also started to focus on glycan engineering by:   
1) Generating for the first time homogenous glycosylation patterns, thus alleviating  
“microheterogeneity” [69]. 
2) Improving both circulation time and tissue specificity of proteins based on different 
glycosylation patterns [70••]. 
3) Identifying carbohydrate analogues with higher affinity against putative targets using 
novel cell based glycan arrays, that better simulate the in vivo environment [62••]. 
We would like to point the readers to the book: “Essentials of Glycobiology”, chapters 56-60 
[71], which very well explains the history of methods, techniques and therapeutics developed 
using glycosylation engineering. We would like to emphasize the rapid rhythm at which new, 
state-of-the-art biological tools in the realm of glycobiology are being generated. We know that 
different glycosylation patterns will affect: the molecular weight, charge and solubility of a 
protein, however, how to control these properties was until recently a conundrum. It has been 
shown [66,69,70••] that precise glycoengineering is a very complex process requiring both 
removing certain genes (knock-down) and introducing new ones (knock-in). In order to know 
which proteins to combine to achieve the desired motif, a complete dictionary of 
glycosyltransferases [19••], their functional dependencies [67] and how to target them [65•] is 
required. This type of deconstruction of the glycosylation atlas allows researchers to inspect 
biological functions of specific glycan motifs such as: circulation time and organ specificity 
for enzyme replacement therapy [70••], efficiency and safety of erythropoietin [72] and 
osteoclast formation [62••]. 
Even though early glycoengineering efforts used a structural based approach for developing 
zanamivir [73] and oseltamivir [74] against influenza virus, much of our current knowledge 
about the glycocalyx and host-pathogen interactions is disjunct from structural biochemistry. 
 10 
The only way to characterize protein-glycan interfaces at the atomic level, is to have accurate 
structural information about glycans. 
Conclusions 
We now know that almost every human disease involves glycans at a step in its evolution [75]. 
Our knowledge of glycan-binding proteins is increasing at a very fast pace, however, 
carbohydrates still remain “the dark matter of biology”. This review focuses on the current 
structural glycome landscape and its shortcomings. One caveat of the carbohydrate-related 
structural information is the fact that it is highly prone to human mistakes. The main emphasis 
of this article is that we need to rethink and redesign the way we store the structural data of 
glycans. Looking forward, we will need to generate exhaustive and curated datasets of 
structures containing carbohydrates to harvest the full potential of emerging research 
techniques, such as deep learning. Furthermore, combining computational biology, structural 
biochemistry, molecular biology and genetics will be crucial in order to achieve a better 
understanding of glycobiology and provide a uniform stream of knowledge.  
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Figure Legends: 
Figure 1: Structural statistics of carbohydrate moieties and glycan binding proteins. A) Venn 
diagram of four largest and their respective last updated datasets. B) Percentage per year of 
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Table 1: Glycan repositories. 
Name Description URL Citation 
GlyTouCan 
Largest glycan structure 
repository  https://glytoucan.org/ 
Tiemeyer  et 
al. 2017 [14•] 
Unilectin 3D 





Bonnardel  et 
al. 2019 [15] 
Glyco 3D 
Structural Database of lectins, 

















Liviu el al. 
2019 [4•] 
CSDB 
structural, taxonomic, NMR 




Toukach  et 













Utilization Loci annotation 
 http://www.cazy.org/
PULDB_new/ 
 Terrapon et 
al. 2018 [20] 
EPS DB 
Bacterial Exopolysaccharide 




Birch et al. 
2019 [21] 
Matrix DB 




Clerc et al. 
2019 [22]  
DAGR 
Database of Anti-Glycan 

















Table 2 Software for glycome prediction, modelling and validation.  
Name Description URL Citation 
Glycan Reader PDB Sugar identification and simulation preparation 
http://glycanstructure.org
/glycanreader/ 
Park et al. 
2017 [5•] 






Glycan Modeller Modelling N-/O-glycosylation on the target protein 
http://glycanstructure.org
/glycanmodeler 
Park et al. 
2019 [49••] 









carbohydrate polymers preparation 







Automated building of 
lipopolysaccharide‐rich bacterial 




et al. 2019 
[51] 
LPS Modeller Modelling lipopolysaccharides http://charmm-gui.org/?doc=input/lps 
Lee et al. 
2019 [52•] 




Lee et al. 
2019 [52•] 
GAG Builder Modeling 3D structures of glycosaminoglycans www.glycam.org/gag 
Singh et al. 
2019 [53] 







Seq prediction for N-/O-
linked glycosylation sites of human 





et al. 2019 
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